Patient group N = 45 | Control group N = 35 | Test of significance | p | |
---|---|---|---|---|
ESR 1st h (mm/h) | 34.1 ± 16.9 | 4.7 ± 1.32 | 10.25 | < 0.001* |
RF( IU) median (min-max | 50 (0–150) | 5 (2–9) | U = 205.5* | < 0.001* |
CRP (mg/dl) median (min-max) | 60 (2–96) | 1.0 (0.0–2.0) | U = 6.5 | < 0.001* |
ACCP (U/ml) Median (min-max | 70 (10–220) | 17 (10–27) | U = 228.5* | < 0.001* |
Serum 14-3-3 η (ng/ml) Median (min-max | 0.45 (0.14–0.69) | 0.14 (0.07–0.34) | U = 68.5* | < 0.001* |
Serum Sema3A (ng/ml) Median (min-max | 3.9 (1.8–6.1) | 6.5 (2.1–8) | U = 1345.0* | < 0.001* |